Ginkgo Bioworks Holdings Inc vs Lufax Holding Ltd — how do they compare? Ginkgo Bioworks Holdings Inc trades at $9.06 (market cap $590.53M), while Lufax Holding Ltd trades at $1.31 (market cap $2.41B). The key difference: Lufax Holding Ltd is far larger — about 4.1× Ginkgo Bioworks Holdings Inc's market cap, and Ginkgo Bioworks Holdings Inc is trading nearer its 52-week high, Lufax Holding Ltd nearer its low. Which is the better fit depends on your goals.
| DNA | LU | |
|---|---|---|
Market Cap | $590.53M | $2.41B |
Sector | Health | Technology |
52-Week High | $16.14 | $4.40 |
52-Week Low | $5.48 | $1.23 |
Enterprise Value | $627.78M | — |
Trailing returns across standard periods
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →Lufax Holding Ltd is a leading financial technology (fintech) platform in China. The company operates a technology-driven personal financial services platform that offers a wide range of loans and wealth management products to its users. Lufax primarily serves the rapidly growing wealth and consumption needs of China’s mass affluent and affluent populations through a combination of its digital platform and an extensive offline network.
Read more on LU →